doc. MUDr. Daniela Žáčková, Ph.D.
Associate professor, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2838, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 218
2015
-
Ponatinib v léčbě leukemií s pozitivním Philadelphským chromosomem : Komentář ke studii
Farmakoterapie, year: 2015, volume: 11, edition: 3
-
Ponatinib, tyrosinkinázový inhibitor třetí generace, v léčbě pacientů s chronickou myeloidní leukemií
Farmakoterapie, year: 2015, volume: 11, edition: 5
-
Problematika chronické myeloidní leukemie u seniorů
Geriatrická onkologie, edition: 1. vydání, year: 2015, number of pages: 9 s.
-
Tyrozinkinázové inhibitory v léčbě starších pacientů s chronickou myeloidní leukemií – editorial
Vnitřní lékařství, year: 2015, volume: 61, edition: 9
2014
-
AUTONOMIC DYSFUNCTION IS AUGMENTED DURING THERAPY, BUT CAN BE IMPROVED BY PHYSICAL EXERCISE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY. RESULTS OF A PILOT TRIAL.
Year: 2014, type: Conference abstract
-
BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing
American Journal of Hematology, year: 2014, volume: 89, edition: 10, DOI
-
No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia
Hematological Oncology, year: 2014, volume: 32, edition: 2, DOI
-
Older patients with chronic myeloid leukemia (a parts per thousand yen65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV
Annals of hematology, year: 2014, volume: 93, edition: 7, DOI
-
Prospective analysis of low-level BCR-ABL1 T315I mutation in CD34+ cells of patients with de novo chronic myeloid leukemia
LEUKEMIA & LYMPHOMA, year: 2014, volume: 55, edition: 8, DOI
2013
-
Akutní myeloidní leukémie : informace pro pacienty a jejich blízké
Year: 2013, type: